In recent years, academic institutions and companies in the neurosciences field have been generating brain data—such as MRIs and EEGs—at an unprecedented rate. This rapid growth in raw, noisy, and unprocessed data has created a pressing need for tools that can extract meaningful insights. CoveConnect™ bridges the gap between neuroscience and data engineering by combining advanced tools with machine learning technology. It enables neuroscience companies to process and interpret MRI and EEG data, while also conducting large-scale brain connectivity modeling. This innovation is paving the way for the next paradigm in neuroscience and brain health. In this video, Dr. Nardin Samuel, CEO & Co-Founder, introduces Cove Neurosciences, outlining its goals, business model, and significance.
In this podcast, Dr. Nardin Samuel, Co-Founder of Cove Neurosciences, shares her insights into how AI reshapes healthcare, from disease detection to treatment optimization. Dr. Samuel discusses the ethical challenges in using AI for clinical decision-making, the role of big data in driving healthcare innovation, and strategies to ensure unbiased AI algorithms in diverse patient populations.
